• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1804250-15
Device Problems Unintended System Motion (1430); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/20/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure was to treat a 99% stenosed de novo lesion in the proximal left anterior descending (plad).Pre-dilatation was performed.The 2.5x15mm xience skypoint stent delivery system (sds) was prepped (air aspiration) outside the anatomy prior to use.The sds was advanced to the target lesion; however, the balloon ruptured during the first inflation at 3 or 4 atmospheres.The stent was noted as not sufficiently deployed due to the balloon rupture.Therefore, the sds was removed and a non-abbott balloon was used to fully deploy the xience skypoint stent.During deployment the stent became displaced about 2mm from the intended implant position; however, the stent was implanted in the target lesion.There was no adverse patient sequela and no clinically significant delay in procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported material rupture was confirmed.The reported unintended system motion could not be replicated in a testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported material rupture; however, factors that may contribute to material ruptures include, but are not limited to, material damage, materials, inflation technique, interactions with other devices, lesion calcification and tortuosity or insufficient preparation prior to use.The product risk assessment identifies this as a foreseeable event; as such, design and manufacturing controls and mitigations have been established for potential causes.There was no damage noted to the sds during the inspection prior to use or during preparation for use which suggests a product quality issue did not contribute to the reported difficulties.In this case, it is possible the device became damaged due to interaction with accessory devices and/or the 99% stenosed lesion during the procedure, thus causing the reported material rupture (balloon pinhole); however, this cannot be confirmed.The reported unintended system motion and treatment appears to be related to operational context of the procedure as it is likely the balloon catheter used for post-dilation interacted with the deployed stent causing the reported unintended system motion.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17740769
MDR Text Key323331623
Report Number2024168-2023-10022
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233074
UDI-Public08717648233074
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1804250-15
Device Lot Number3010241
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/09/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/05/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/29/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-